CTOs on the Move

CODA Biotherapeutics

www.codabiotherapeutics.com

 
CODA Biotherapeutics` revolutionary chemogenetic platform aims to control the activity of cells to treat disease. With chemogenetics, the goal is to modify a target cell population using gene therapy to express a tunable `switch` protein. Cells modified with the `switch` can be activated or inactivated in a dose-dependent manner by a subsequently administered small molecule therapeutic, an effect that should only occur in the modified cells.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

CODA Biotherapeutics raised $19M on 10/03/2018
CODA Biotherapeutics raised $15M on 11/05/2019

Similar Companies

The Oncology Institute of Hope and Innovation

The Oncology Institute of Hope and Innovation is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Evelo Therapeutics

Evelo Therapeutics is the latest breakthrough microbiome company from Flagship VentureLabs, the innovation foundry of Flagship Ventures.

Genosco

Genosco is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gliknik

Gliknik Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders.

Applied Therapeutics

Applied Therapeutics is a clinical-stage biopharmaceutical company that uses our novel drug-development approach to create transformative, life-changing treatments for the patients who desperately need them.